These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7585118)

  • 1. A single-injection protein kinase A-directed antisense treatment to inhibit tumour growth.
    Nesterova M; Cho-Chung YS
    Nat Med; 1995 Jun; 1(6):528-33. PubMed ID: 7585118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase A-directed antisense restrains cancer growth: sequence-specific inhibition of gene expression.
    Cho-Chung YS
    Antisense Nucleic Acid Drug Dev; 1996; 6(3):237-44. PubMed ID: 8915509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense-protein kinase A: a single-gene-based therapeutic approach.
    Cho-Chung YS; Nesterova M; Kondrashin A; Noguchi K; Srivastava R; Pepe S
    Antisense Nucleic Acid Drug Dev; 1997 Jun; 7(3):217-23. PubMed ID: 9212914
    [No Abstract]   [Full Text] [Related]  

  • 4. Antisense DNA toward type I protein kinase A produces sustained inhibition of tumor growth.
    Cho-Chung YS
    Proc Assoc Am Physicians; 1997 Jan; 109(1):23-32. PubMed ID: 9010913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compensatory stabilization of RIIbeta protein, cell cycle deregulation, and growth arrest in colon and prostate carcinoma cells by antisense-directed down-regulation of protein kinase A RIalpha protein.
    Nesterova M; Noguchi K; Park YG; Lee YN; Cho-Chung YS
    Clin Cancer Res; 2000 Sep; 6(9):3434-41. PubMed ID: 10999726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental gene therapy of human colon cancer.
    Bold RJ; Warren RE; Ishizuka J; Cho-Chung YS; Townsend CM; Thompson JC
    Surgery; 1994 Aug; 116(2):189-95; discussion 195-6. PubMed ID: 8047985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIalpha subunit.
    Nesterova M; Cho-Chung YS
    Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):423-33. PubMed ID: 11198926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells.
    Yokozaki H; Budillon A; Tortora G; Meissner S; Beaucage SL; Miki K; Cho-Chung YS
    Cancer Res; 1993 Feb; 53(4):868-72. PubMed ID: 8428367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
    Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth arrest and induction of apoptosis in breast cancer cells by antisense depletion of protein kinase A-RI alpha subunit: p53-independent mechanism of action.
    Srivastava RK; Srivastava AR; Seth P; Agrawal S; Cho-Chung YS
    Mol Cell Biochem; 1999 May; 195(1-2):25-36. PubMed ID: 10395066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of growth of human tumor cell lines in nude mice by an antisense of oligonucleotide inhibitor of protein kinase C-alpha expression.
    Dean N; McKay R; Miraglia L; Howard R; Cooper S; Giddings J; Nicklin P; Meister L; Ziel R; Geiger T; Muller M; Fabbro D
    Cancer Res; 1996 Aug; 56(15):3499-507. PubMed ID: 8758918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.
    Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; Pepe S; Bianco AR; Agrawal S; Mendelsohn J; Tortora G
    J Natl Cancer Inst; 1998 Jul; 90(14):1087-94. PubMed ID: 9672257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulatory subunit of cAMP-dependent protein kinase as a target for chemotherapy of cancer and other cellular dysfunctional-related diseases.
    Cho-Chung YS; Clair T
    Pharmacol Ther; 1993 Nov; 60(2):265-88. PubMed ID: 8022860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity and pharmacokinetics of a mixed-backbone antisense oligonucleotide targeted to the RIalpha subunit of protein kinase A after oral administration.
    Wang H; Cai Q; Zeng X; Yu D; Agrawal S; Zhang R
    Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13989-94. PubMed ID: 10570186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the circuitry of protein kinase A and cAMP signaling in cancer genesis: antisense, microarray, gene overexpression, and transcription factor decoy.
    Cho-Chung YS; Nesterova M; Becker KG; Srivastava R; Park YG; Lee YN; Cho YS; Kim MK; Neary C; Cheadle C
    Ann N Y Acad Sci; 2002 Jun; 968():22-36. PubMed ID: 12119265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative antitumor effect of mixed backbone oligonucleotides targeting protein kinase A in combination with cytotoxic drugs or biologic agents.
    Tortora G; Caputo R; Damiano V; Bianco R; Pepe S; Pomatico G; Bianco AR; Jiang Z; Agrawal S; Ciardiello F
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):141-5. PubMed ID: 9593054
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined targeted inhibition of bcl-2, bcl-XL, epidermal growth factor receptor, and protein kinase A type I causes potent antitumor, apoptotic, and antiangiogenic activity.
    Tortora G; Caputo R; Damiano V; Caputo R; Troiani T; Veneziani BM; De Placido S; Bianco AR; Zangemeister-Wittke U; Ciardiello F
    Clin Cancer Res; 2003 Feb; 9(2):866-71. PubMed ID: 12576461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral antisense that targets protein kinase A cooperates with taxol and inhibits tumor growth, angiogenesis, and growth factor production.
    Tortora G; Bianco R; Damiano V; Fontanini G; De Placido S; Bianco AR; Ciardiello F
    Clin Cancer Res; 2000 Jun; 6(6):2506-12. PubMed ID: 10873106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase.
    Tortora G; Yokozaki H; Pepe S; Clair T; Cho-Chung YS
    Proc Natl Acad Sci U S A; 1991 Mar; 88(5):2011-5. PubMed ID: 2000408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-catenin antisense treatment decreases beta-catenin expression and tumor growth rate in colon carcinoma xenografts.
    Green DW; Roh H; Pippin JA; Drebin JA
    J Surg Res; 2001 Nov; 101(1):16-20. PubMed ID: 11676549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.